About the Company

Company Name Quantum Operation Inc.
Representative Yoshihiro Yoshida
Establishment October 26, 2017
Capital Stock 100,000,000 JPY (As of March 31, 2025)
Location 5F, Zephyros Aoyama, 8-2-16 Akasaka, Minato-ku, Tokyo, 107-0052, Japan
Number of employees 5, including executives and contract workers (As of March 31, 2025)
Shareholders
Taisho Pharmaceutical Co.,
Alfresa Corporation,
Tomita Pharmaceutical Co. and more
Corresponding Banks
Sumitomo Mitsui Banking Corporation,
Nihonbashi Branch and more
Business Alliances and Business Partners
Xunlong Software (Shenzhen and Dongguan, China),
enstem Inc.,

History of the Company

October 2017Established
October 2017Business partnership with Xunlong Software (Shenzhen and Dongguan, China)
November 2017Began the vital data acquisition IoT sensor business.
August 2018First prototype of the first IoT sensor for acquiring vital data completed.
March 2019Have commenced third-party allotment of shares through equity crowdfunding.
July 2019Business partnership with Tomita Pharmaceutical Co.
November 2019Business partnership with Taisho Pharmaceutical Co.
January 2020Business partnership with Alfresa Corporation.
February 2020Start of joint research with Chiba University of Science.
June 2020Pre-release of the Heat Stroke Prediction System.
July 2020Selected to represent Japan at the Global Innovation Forum in Osaka 2020 (GIF).
August 2020Completed registration of medical device manufacturing business.
September 2020Obtained medical device certification for Heartbeat, Respiration, and Body Movement Detection Sheet Sensor.
November 2020Appeared in Nikkei Digital Health: Japanese companies are taking on the challenge of Wearable Medical Devices and creating a new market on the strength of the accuracy of their devices.
November 2020Listed as a participating start-up company in Saitama Sports Start-up (SSS).
December 2020Participated in Healthtech/SUM 2020.
December 2020Participated in a Study Group on Forming Rules for a Harm Reduction Lifestyle.
December 2020Obtained Type II Medical Device Manufacturing and Sales License.
January 2021Exhibited at CES2021. Elected as “Best of CES2021 finalist” by Engadget.com
April 2021Appeared in Forbes Japan.
June 2021Started joint research about “VINSTA” with AstraZeneca.
June 2021Exhibited at Arab Health 2021.
September 2021Finalists selected for “Mastermind Competition” in Luxembourg.
October 2021Exhibit at GITEX Future Stars.
Selected as a semifinalist for the Supernova Challenge.
November 2021CES 2022 Innovation Awards Winner.
 December 2021 Business partnership with Fukoku Bussan Co., Ltd.
January 2022Exhibited at CES2022
Medtronic APAC Innovation Challenge Top10 finalist